Proton MR spectroscopy in clinical routine
暂无分享,去创建一个
[1] D. Arnold,et al. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. , 1999, Archives of neurology.
[2] R. Kreis,et al. Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. , 1996, The Journal of clinical investigation.
[3] D. Arnold,et al. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images , 1994, Annals of neurology.
[4] K. Laxer. Clinical Applications of Magnetic Resonance Spectroscopy , 1997, Epilepsia.
[5] P R Luyten,et al. Observation of metabolites in the human brain by MR spectroscopy. , 1986, Radiology.
[6] A R Tate,et al. Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.
[7] D. Gadian,et al. Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.
[8] D Shedid,et al. MRS Metabolic Markers of Seizures and Seizure‐Induced Neuronal Damage , 1998, Epilepsia.
[9] P M Pattany,et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. , 2000, AJNR. American journal of neuroradiology.
[10] L. Kappelle,et al. Cerebral metabolic changes in patients with a symptomatic occlusion of the internal carotid artery: A longitudinal 1H magnetic resonance spectroscopy study , 2000, Journal of magnetic resonance imaging : JMRI.
[11] U. Klose,et al. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. , 1991, Radiology.
[12] E. Achten,et al. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy. , 1997, AJNR. American journal of neuroradiology.
[13] E. Laws. Imaging brain tumors — beyond three dimensions , 1996, Nature Medicine.
[14] A R Tate,et al. Lipid metabolite peaks in pattern recognition analysis of tumour in vivo MR spectra. , 1996, Anticancer research.
[15] M. Weiner,et al. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. , 2000, Radiology.
[16] Matthijs Oudkerk,et al. 1H MR Spectroscopy Detection of Lipids and Lactate in Metastatic Brain Tumors , 1996, NMR in biomedicine.
[17] Brian D. Ross,et al. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .
[18] D. Arnold,et al. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors , 1998, NMR in biomedicine.
[19] J Hennig,et al. Grading and therapy monitoring of astrocytomas with 1H-spectroscopy: preliminary study. , 1996, Anticancer research.
[20] R. Kuzniecky,et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging , 1996, Annals of neurology.
[21] D. Gadian,et al. H magnetic resonance spectroscopy in the investigation of intractable epilepsy , 1994, Acta neurologica Scandinavica. Supplementum.
[22] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[23] C. Arús,et al. Diagnosis of Brain Abscess by Magnetic Resonance Spectroscopy. Report of Two Cases , 1997 .
[24] B J Soher,et al. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.
[25] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[26] H Soltanian-Zadeh,et al. Brain tumor segmentation and characterization by pattern analysis of multispectral NMR images , 1998, NMR in biomedicine.
[27] M. Castillo,et al. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. , 1998, Magnetic resonance imaging clinics of North America.
[28] J. McConnell,et al. Proton spectroscopy of brain glutamine in acute liver failure , 1995, Hepatology.
[29] D. Arnold. Magnetic resonance spectroscopy: imaging axonal damage in MS , 1999, Journal of Neuroimmunology.
[30] B. Rosen,et al. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10 , 1997, Annals of neurology.
[31] G J Barker,et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.
[32] B. Ross,et al. The biochemistry of living tissues: Examination by MRS , 1992, NMR in biomedicine.
[33] J. D. de Certaines,et al. Magnetic resonance spectroscopy in cancer: phospholipid, neutral lipid and lipoprotein metabolism and function. , 1996, Anticancer research.
[34] P M Matthews,et al. Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis. , 2000, Magnetic resonance imaging.
[35] Roland Kreis,et al. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.
[36] K. McCully,et al. Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems. , 1999, Chest.
[37] D M Doddrell,et al. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. , 1999, Magnetic resonance imaging.
[38] New NMR measurements in epilepsy. T2 relaxometry and magnetic resonance spectroscopy. , 1999, Advances in neurology.
[39] F Ståhlberg,et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. , 2000, AJNR. American journal of neuroradiology.
[40] R L Somorjai,et al. Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.
[41] J Kurhanewicz,et al. The prostate: MR imaging and spectroscopy. Present and future. , 2000 .
[42] F. Podo,et al. Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. , 1996, Anticancer research.
[43] M. Castillo,et al. Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.
[44] J. Frahm,et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.
[45] P. M. Matthews,et al. Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders , 1995, Neurology.
[46] K. Hara,et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.
[47] Mark Noble,et al. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.
[48] D. Arnold,et al. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging , 1998, Annals of neurology.
[49] loannis Constantinidis. MAGNETIC RESONANCE SPECTROSCOPY AND THE PRACTICING NEUROLOGIST , 1998 .
[50] N. Makris,et al. An Integrated Strategy for Evaluation of Metabolic and Oxidative Defects in Neurodegenerative Illness Using Magnetic Resonance Techniques , 1999, Annals of the New York Academy of Sciences.
[51] J. Langston,et al. Proton MR spectroscopy of pediatric brain tumors. , 1998, Neuroimaging clinics of North America.
[52] N. Lundbom,et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997, Journal of Neurosurgery.
[53] G. Hagberg,et al. From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods , 1998, NMR in biomedicine.
[54] S. Holtås,et al. In vivo proton MR spectroscopy of untreated and treated brain abscesses. , 1999, AJNR. American journal of neuroradiology.
[55] Der,et al. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. , 1990, Radiology.
[56] A. R. Tate,et al. Pattern recognition analysis , 1998 .
[57] C Morriss,et al. Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks. , 1997, Journal of neurosurgery.
[58] J Hennig,et al. Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.
[59] M. Castillo,et al. Proton MR spectroscopy of common brain tumors. , 1998, Neuroimaging clinics of North America.